Zevalin

Ibritumomab tiuxetan, also sold under the trade name Zevalin®, is a monoclonal antibody radioimmunotherapy treatment for some forms of B cell non-Hodgkin's lymphoma, a myeloproliferative disorder of the lymphatic system. The drug uses the monoclonal mouse IgG1 antibody ibritumomab (pronounced as <ih bri TYOO mo mab>) in conjunction with the chelator tiuxetan, to which a radioactive isotope (either yttrium-90 or indium-111) is added.
See more at Wikipedia.org...

Ibritumomab tiuxetan Warning - Hazardous drug! Zevalin Pharmacologic class: Monoclonal antibody Therapeutic class: Antineoplastic Pregnancy risk [more]Zevalin - Community and Resources